Literature DB >> 14972242

Surgical management of chronic pancreatitis and the role of islet cell autotransplantation.

Thomas S Helling1.   

Abstract

Chronic pancreatitis is a disease characterized by disabling pain, inability to eat, steatorrhea, and eventual malnutrition. This often results in repeated hospitalizations and attempts to control symptoms with various analgesic regimens. As a result, the medical treatment of chronic pancreatitis is one of symptomatic management. Eventually, in some, nutritional supplementation becomes a necessity. For a fortunate few, the disease apparently burns itself out in time, lessening pain and improving appetite. In many patients, frustration over pain management and repeated hospitalizations leads to surgical treatment. Various procedures have been devised but, generally, fall into 2 categories: operations to decompress dilated ducts and operations to resect diseased pancreas. Results with either approach are unpredictable and often unsuccessful. For those without dilated ducts or with recurrent pain after surgery, total pancreatectomy has been suggested to remove all inflammatory tissue. This can be coupled with islet cell autotransplantation to avoid the dangers of pancreatogenic diabetes. Appropriate care of the removed pancreas and islet cell separation and purification are critical to this procedure to produce viable cells. Dispersed islets have been shown to successfully engraft and function for indefinite periods of time. Although insulin independence may not be achieved, easier maintenance of blood glucose can usually be realized.

Entities:  

Mesh:

Year:  2003        PMID: 14972242     DOI: 10.1016/S0149-7944(02)00789-4

Source DB:  PubMed          Journal:  Curr Surg        ISSN: 0149-7944


  6 in total

1.  Total pancreatectomy with islet autotransplantation: an overview.

Authors:  Seok L Ong; Gianpiero Gravante; Cristina A Pollard; M'balu A Webb; Severine Illouz; Ashley R Dennison
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

2.  Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome.

Authors:  Massimo Venturini; Claudio Sallemi; Caterina Colantoni; Giulia Agostini; Gianpaolo Balzano; Antonio Esposito; Antonio Secchi; Francesco De Cobelli; Massimo Falconi; Lorenzo Piemonti; Paola Maffi; Alessandro Del Maschio
Journal:  Br J Radiol       Date:  2016-06-21       Impact factor: 3.039

3.  Total pancreatectomy and islet autotransplantation: A decade nationwide analysis.

Authors:  Reza Fazlalizadeh; Zhobin Moghadamyeghaneh; Aram N Demirjian; David K Imagawa; Clarence E Foster; Jonathan R Lakey; Michael J Stamos; Hirohito Ichii
Journal:  World J Transplant       Date:  2016-03-24

Review 4.  Adult stem or progenitor cells in treatment for type 1 diabetes: current progress.

Authors:  Yu Huan T Liao; C Bruce Verchere; Garth L Warnock
Journal:  Can J Surg       Date:  2007-04       Impact factor: 2.089

Review 5.  Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology.

Authors:  Massimo Venturini; Claudio Sallemi; Paolo Marra; Anna Palmisano; Giulia Agostini; Carolina Lanza; Gianpaolo Balzano; Massimo Falconi; Antonio Secchi; Paolo Fiorina; Lorenzo Piemonti; Paola Maffi; Antonio Esposito; Francesco De Cobelli; Alessandro Del Maschio
Journal:  Gland Surg       Date:  2018-04

6.  How much of the pancreatic head should we resect in Frey's procedure?

Authors:  Naoaki Sakata; Shinichi Egawa; Fuyuhiko Motoi; Masafumi Goto; Seiki Matsuno; Yu Katayose; Michiaki Unno
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.